Relationship between obstructive sleep apnea-hypopnea syndrome (OSAHS) and liver fibrosis
Methods: The patients who underwent polysomnographic (PSG) examinations in the outpatient and inpatient departments of our hospital between December 2010 and June 2013 were selected. The patients were divided into two groups based on the apnea-hypopnea index (AHI; OSAHS and non-OSAHS patients), and both groups were further divided based on obesity and normal body weight based on the body mass index (BMI). Sleep breathing indicators, including BMI, AHI, LSaO2, and MSaO2, were measured in all patients. All of the patients had their blood drawn on the morning after the day of the PSG examination, and the samples were sent to the biochemical laboratory of our hospital for determination of the levels of HA, PIII, IVC, and LN.
Results: Among the obese and normoweight patients, the levels of HA, PIII, IVC, and LN in OSAHS patients were higher than the non-OSAHS patients (P value <0.05). Amongst the OSAHS and non-OSAHS patients, the levels of HA, PIII, IVC, and LN in the obese patients were also higher than the non-obese patients (P value <0.05). The levels of HA, PIII, IVC, and LN in the obese OSAHS patients were higher than the remaining three groups (P value <0.05). The levels of HA, PIII, IVC, and LN had positive correlations with the AHI and BMI (r=0.701, 0.523, 0.639, and 0.421, respectively, P<0.05; and r=0.565, 0.441, 0.475, and 0.401, respectively, P<0.05), and negative correlations with the LSaO2 and MSaO2 in OSAHS patients (r=‐0.432, ‐0.394, ‐0.403, and ‐0.267, respectively, P<0.05; and r=‐0.591, ‐0.517, ‐0.533, and ‐0.484, respectively, P<0.05).
Conclusion: The levels of plasma HA, PIII, IVC, and LN in OSAHS patients were related to OSAHS. OSAHS might lead to liver fibrosis.
Document Type: Research Article
Publication date: September 1, 2014
Family Medicine and Community Health (FMCH) is an open-access journal focusing on subjects that are common and relevant to family medicine/general practice and community health. The journal publishes relevant content across disciplines such as epidemiology, public health, social and preventive medicine, research and evidence based medicine, community health service, patient education and health promotion and health ethics. The journal has a specific focus on the management of chronic illness particularly diabetes, ischaemic heart disease, chronic heart failure, hypertension, bronchial asthma, chronic obstructive airways disease and common mental illness. FMCH is published by Compuscript http://www.compuscript.com on behalf of the Chinese General Practice Press http://www.chinagp.net.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites